DOXIUM

This brand name is authorized in Austria, Ecuador, France, Hong Kong SAR China, Mexico, Poland, Romania, Spain, Turkey.

Active ingredients

The drug DOXIUM contains one active pharmaceutical ingredient (API):

1	Calcium dobesilate UNII 5921X1560Q - CALCIUM DOBESILATE
	Calcium dobesilate is a regulator of capillary functions. Calcium dobesilate acts on the capillary walls by regulating its impaired physiological functions – increased permeability and decreased resistance. It increases erythrocyte flexibility, inhibits platelet hyperaggregation and, in diabetic retinopathy, it reduces plasma and blood hyperviscosity, thus improving blood rheological properties and tissue irrigation.
	Read more about Calcium dobesilate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C05BX01	Calcium dobesilate	C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BX Other sclerosing agents
Discover more medicines within C05BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28610-10-08
ES	Centro de información online de medicamentos de la AEMPS	54553
FR	Base de données publique des médicaments	64081901
HK	Department of Health Drug Office	34950
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	012M80
PL	Rejestru Produktów Leczniczych	100122941
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68800001, W68800002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699514091035, 8699514091042, 8699514154457, 8699514154464